Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Total Costs of Care during Chimeric Antigen Receptor T-Cell Therapy in Patients with Relapsed/Refractory B Cell Non-Hodgkin Lymphoma: A Large Private Insurance Claim-Based Analysis

Mengyang Di, Jessica B Long, Iris Isufi, Francine M. Foss, Stuart Seropian, Cary P Gross, Scott F. Huntington

Blood (2022) 140 (Supplement 1): 10818–10819.

https://doi.org/10.1182/blood-2022-164915

Published: 2022

Journal Articles

Cost-effectiveness of first-line vs third-line ibrutinib in patients with untreated chronic lymphocytic leukemia

Kishan K. Patel, Iris Isufi, Shalin Kothari, Amy J. Davidoff, Cary P. Gross, Scott F. Huntington

Blood (2020) 136 (17): 1946–1955.

https://doi.org/10.1182/blood.2020004922

Published: 2020

Includes: Supplemental data

Journal Articles

Utilization and Early Discontinuation of First-Line Ibrutinib for Patients with Chronic Lymphocytic Leukemia Treated in the Community Oncology Setting in the United States

Scott F. Huntington, MD MPH, Pamela R. Soulos, Paul M. Barr, MD, Ryan Jacobs, MD, Frederick Lansigan, MD, Oreofe O. Odejide, MD MPH, Lee S. Schwartzberg, MD, Amy J. Davidoff, PhD MS, Cary P Gross, MD

Blood (2019) 134 (Supplement_1): 797.

https://doi.org/10.1182/blood-2019-122054

Published: 2019

Journal Articles

Association between Oncologist Ownership of Imaging Facilities and Utilization: An Analysis of Positron-Emission Tomography (PET) Use in Lymphoma Settings with Variable PET Utility

Scott F Huntington, MD MPH, Weiwei Zhu, MPH, Jessica Hoag, PhD, Rong Wang, PhD, Amer M. Zeidan, MBBS, MHS, Smith Giri, MBBS, Nikolai A. Podoltsev, MD PhD, Steven D. Gore, MD, Xiaomei Ma, MD PhD, Cary P Gross, MD, Amy J. Davidoff, PhD MS

Blood (2018) 132 (Supplement 1): 3538.

https://doi.org/10.1182/blood-2018-99-115140

Published: 2018

Journal Articles

Financial Incentives and Rituximab Maintenance: Association of Treatment Location with Prolonged Maintenance in Non-Hodgkin Lymphoma Patients Treated in the United States

Scott Huntington, MDMPH, Jessica Hoag, PhD, Weiwei Zhu, Ms, Cary P Gross, MD, Amy J. Davidoff, PhD MS

Blood (2017) 130 (Supplement 1): 2120.

https://doi.org/10.1182/blood.V130.Suppl_1.2120.2120

Published: 2017

Journal Articles

Comparative Effectiveness of Azacitidine Versus Decitabine Among Older Adults Diagnosed with Higher-Risk Myelodysplastic Syndromes (HR-MDS)

Amer M. Zeidan, MBBS, MHS, Jessica B. Long, PhD, Jane Hall, Rong Wang, PhD, Scott F Huntington, MDMPH, Gregory Abel, MD MPH, Thomas Prebet, MD, Nikolai A. Podoltsev, MDPhD, Cary P. Gross, MD, Steven D. Gore, MD, Xiaomei Ma, PhD, Amy J. Davidoff, PhD

Blood (2015) 126 (23): 3285.

https://doi.org/10.1182/blood.V126.23.3285.3285

Published: 2015

Journal Articles

Myelodysplastic Syndromes and Acute Myeloid Leukemia in Prostate Cancer Patients after Radiotherapy, a Population-Based Study

Rong Wang, PhD, Amer M. Zeidan, MBBS, MHS, Pamela R Soulos, MPH, James B. Yu, MD, Amy J. Davidoff, PhD, Steven D. Gore, MD, Cary P. Gross, MD, Xiaomei Ma, PhD

Blood (2015) 126 (23): 3295.

https://doi.org/10.1182/blood.V126.23.3295.3295

Published: 2015

Journal Articles

Lack of Association Between Costs of Care and Overall Survival (OS) Among Medicare Beneficiaries with Myelodysplastic Syndromes (MDS) in the United States (US)

Amer M. Zeidan, MBBS, MHS, Rong Wang, PhD, Amy J. Davidoff, PhD, Steven D. Gore, MD, Pamela R Soulos, MPH, Scott F Huntington, MDMPH, Cary P. Gross, MD, Xiaomei Ma, PhD

Blood (2015) 126 (23): 873.

https://doi.org/10.1182/blood.V126.23.873.873

Published: 2015

Journal Articles

Secondary Myeloid Neoplasms in Older Women with Breast Cancer after Radiotherapy: A Population-Based Study

Amer M. Zeidan, MBBS, MHS, Jessica B. Long, PhD, Rong Wang, PhD, James B. Yu, MD, Jane Hall, Gregory Abel, MD MPH, Steven D. Gore, MD, Cary P. Gross, MD, Xiaomei Ma, PhD, Amy J. Davidoff, PhD

Blood (2015) 126 (23): 1676.

https://doi.org/10.1182/blood.V126.23.1676.1676

Published: 2015

NARROW

Total Costs of Care during Chimeric Antigen Receptor T-Cell Therapy in Patients with Relapsed/Refractory B Cell Non-Hodgkin Lymphoma: A Large Private Insurance Claim-Based Analysis

Cost-effectiveness of first-line vs third-line ibrutinib in patients with untreated chronic lymphocytic leukemia

Utilization and Early Discontinuation of First-Line Ibrutinib for Patients with Chronic Lymphocytic Leukemia Treated in the Community Oncology Setting in the United States

Association between Oncologist Ownership of Imaging Facilities and Utilization: An Analysis of Positron-Emission Tomography (PET) Use in Lymphoma Settings with Variable PET Utility

Financial Incentives and Rituximab Maintenance: Association of Treatment Location with Prolonged Maintenance in Non-Hodgkin Lymphoma Patients Treated in the United States

Comparative Effectiveness of Azacitidine Versus Decitabine Among Older Adults Diagnosed with Higher-Risk Myelodysplastic Syndromes (HR-MDS)

Myelodysplastic Syndromes and Acute Myeloid Leukemia in Prostate Cancer Patients after Radiotherapy, a Population-Based Study

Lack of Association Between Costs of Care and Overall Survival (OS) Among Medicare Beneficiaries with Myelodysplastic Syndromes (MDS) in the United States (US)

Secondary Myeloid Neoplasms in Older Women with Breast Cancer after Radiotherapy: A Population-Based Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only